The WHO estimates that 1.6 billion people suffer from anaemia. This has prompted the WHO to describe the battle against anaemia as one of its crucial targets for 2025 for sustainable growth.
In view of the need for early detection of blood-free anaemia, Bosch has developed a Portable Haemoglobin Monitor Solution (HMS), especially in regions where routine access to medical care appears to be difficult. This HMS enables several individuals, using a non-invasive method, to be tested for anaemia easily and safely. "The solution was named an Honoree of the CES Innovation Award in “Health and awareness” category.
As a revolutionary approach and as an alternative to conventional approaches for the early detection of anaemia, Bosch has created the non-invasive haemoglobin monitor. Even in resource-restricted cases, this can give people better diagnostic choices. The use of artificial intelligence, especially in point-of-care settings and closer to the patient, is revolutionising anaemia management.
Bosch’s intelligent treatment is intended for use directly at the point of care and is fully pain-free without the need for a blood test, as the value is measured by a finger scanner on the surface of the skin using multi-wavelength spectrophotometry. The system uses an optical sensor to measure the signals of a photoplethysmogram (PPG) accurately and reliably.